Filtered By:
Specialty: General Medicine
Condition: Atrial Fibrillation

This page shows you your search results in order of date. This is page number 17.

Order by Relevance | Date

Total 1009 results found since Jan 2013.

Management of Anticoagulation in Cancer Patients with Atrial Fibrillation
Isr Med Assoc J. 2022 Mar;24(3):183-185.ABSTRACTAtrial fibrillation is becoming an increasingly important problem in cardio-oncology. Specific risk factors for atrial fibrillation occurrence include type of cancer disease and anticancer drugs. Anticoagulation is often abandoned. The CHA2DS2-VASc and CHA2DS2 scores may be important not only in predicting stroke but also in mortality. The role of new direct oral anticoagulants is growing, but they need to be used in a personalized approach depending on the risk of unbeneficial interactions with cancer treatment and the risk of bleeding.PMID:35347933
Source: The Israel Medical Association Journal - March 29, 2022 Category: General Medicine Authors: Sebastian Szmit Jaros ław Kępski Michal Wilk Source Type: research

Atrial Myopathy and Dementia
Dementia is a leading cause of disability and death with an estimate of more than 50 million people living with the disease worldwide, a number that is projected to triple by 2050. Unlike Alzheimer disease, a degenerative condition without proven cure or treatment, vascular dementia is the second most common etiology and opens up opportunities for dementia prevention through treatment of known risk factors such as hypertension and atrial fibrillation (AF). The latter is a known risk factor for dementia through cerebral embolism and ischemic stroke primarily but also through nonstroke mechanisms. Thus, prevention, detection...
Source: JAMA - March 22, 2022 Category: General Medicine Source Type: research

Why do people take part in atrial fibrillation screening? Qualitative interview study in English primary care
Conclusions Participants assessed the SAFER AF screening programme to be a legitimate, relevant and safe screening opportunity, and complied obediently with what they perceived to be a recommendation to take part. Their unreserved acceptance of screening benefit and lack of awareness of potential harms suggests that uptake would be high but reinforces the importance of ensuring participants receive balanced information about AF screening initiatives. Trial registration number ISRCTN16939438; Pre-results.
Source: BMJ Open - March 16, 2022 Category: General Medicine Authors: Hoare, S., Powell, A., Modi, R. N., Armstrong, N., Griffin, S. J., Mant, J., Burt, J., The SAFER Authorship Group, Dymond, Hobbs, Johnson, McManus, Williams Tags: Open access, Public health Source Type: research

A Retrospective Population-Based Survival Study of Idiopathic Pulmonary Arterial Hypertension in Korea
CONCLUSION: The 10-year SR of IPAH was 57% in Korea. The HR for IPAH was significantly high in patients with older age and other risk factors.PMID:35289139 | DOI:10.3346/jkms.2022.37.e80
Source: J Korean Med Sci - March 15, 2022 Category: General Medicine Authors: Shin Yi Jang Eun Kyoung Kim June Huh Jinyoung Song I-Seok Kang Seung Woo Park Duk-Kyung Kim Sung-A Chang Source Type: research

Anticoagulants for people hospitalised with COVID-19
CONCLUSIONS: When compared to a lower-dose regimen, higher-dose anticoagulants result in little to no difference in all-cause mortality and increase minor bleeding in people hospitalised with COVID-19 up to 30 days. Higher-dose anticoagulants possibly reduce pulmonary embolism, slightly increase major bleeding, may result in little to no difference in hospitalisation time, and may result in little to no difference in deep vein thrombosis, stroke, major adverse limb events, myocardial infarction, atrial fibrillation, or thrombocytopenia. Compared with no treatment, anticoagulants may reduce all-cause mortality but the evide...
Source: Cochrane Database of Systematic Reviews - March 4, 2022 Category: General Medicine Authors: Ronald Lg Flumignan Vinicius T Civile J éssica Dantas de Sá Tinôco Patricia If Pascoal Libnah L Areias Charbel F Matar Britta Tendal Virginia Fm Trevisani Álvaro N Atallah Luis Cu Nakano Source Type: research